Health Security Digest

  • Medical press

    New tuberculosis drug may shorten treatment time for patients

    11 February 2019 - Medical Xpress

    The goal of TB drug development programs is to develop universal treatment regimens that will shorten and simplify TB treatment in patients, which typically takes at least six months, and sometimes more than a year. 

  • The star

    Expert: Dengue patients should get tested for Chikungunya, too

    11 February 2019 - The Star

    People living in Chikungunya endemic areas should get themselves tested for the disease other than getting a standard dengue test, says Sungai Buloh Hospital Infectious Disease Unit head Datuk Dr Christopher Lee. While most joint pains from dengue or Chikungunya last up to seven days, some patients suffer for months, and about 10% of them reported joint pains lasting as long as three to five years, and they tend to occur among older patients, he said.

  • Scientific American

    We're Not Using One of Our Best Weapons against Drug-Resistant Microbes

    8 February 2019 - Scienific American

    Seth Berkley

    Antimicrobial resistance (AMR) has been hailed as one of the biggest threats to humanity. The number of deaths caused by drug-resistant bacteria is expected to rise from 700,000 to 10 million a year by 2050. But while the challenges of developing new classes of antibiotics and reducing the use and misuse of existing drugs have dominated the headlines, there is a more immediate and complementary solution: vaccines.

  • Medical press

    Interaction between two immune cell types could be key to better dengue vaccines, study shows

    7 February 2019 - Medical Xpress

    Duke-NUS Medical School

    Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of immune cells that plays an important role in the early fight against dengue virus infection.

  • Deadly drug-resistant TB a 'blinking red' worldwide threat: Global Fund head Peter Sands

    7 February 2019 - Channel NewsAsia

    Deadly, drug-resistant tuberculosis - as lethal as Ebola and tough to treat in even the best hospitals - is a "blinking red" worldwide threat, the head of a global health fund warned in an interview. The Global Fund to Fight AIDS, Tuberculosis and Malaria is on a mission to eradicate the three epidemics and plans to spend around US$12 billion on it over the next three years.

  • Australian scientists work to put bite on mosquito-bourne Zika virus

    7 February 2019 - The Canberra Times

    Stuart Layt

    Dr Prasad Paradkar, a senior research scientist with the CSIRO, has been leading a team working with University of California San Diego to genetically engineer Zika-resistant mosquitoes. Dr Paradkar said currently Zika was being fought with insecticide against the mosquitoes, but there needed to be a more complete solution.

  • Experts Meet in New Delhi to 'Step Up the Fight' Against Malaria and Drug Resistance

    7 February 2019 - The Week

    The Asia Pacific Leaders' Malaria Alliance (APLMA) convened a panel of senior officials today in New Delhi to discuss the global fight to end malaria, outlining strategies to improve collaboration, increase investment and identify innovative approaches to eliminate the disease and stop drug-resistance.

  • The world is too complacent about epidemics. Here's how to change

    7 February 2019 - World Economic Forum

    Julie Louise Gerberding

    No one can predict exactly when or where the next threat will occur, but as we learned from the 2014 West Africa Ebola virus outbreak, and the ongoing Ebola crisis in the Democratic Republic of the Congo (DRC), we live in a world where infectious disease outbreaks with the potential for tragic consequences are a certainty.

  • No Cases of Latent Tuberculosis Reactivation Seen Following Hematopoietic Cell Transplantation

    6 February 2019 - Hematology Advisor

    Sonali Gattani

    The risk of latent tuberculosis infection (LTBI) reactivation following hematopoietic cell transplantation (HCT) may be lower than previously thought, according to an article published in Clinical Infectious Diseases. In this retrospective cohort study, researchers assessed 2531 patients who had undergone autologous or allogeneic HCT between 2010 and 2015.

  • The Importance of Wildlife Disease Monitoring as Part of Global Surveillance for Zoonotic Diseases: The Role of Australia

    6 February 2019 - Multidisciplinary Digital Publishing Institute

    Rupert Woods, et al.,

    Strong cooperative links and coordination mechanisms exist between the human (public health) and animal arms of the health system in Australia. Wildlife is included in this system. The risks to Australia posed by diseases with wildlife as part of their epidemiology will almost certainly become greater with changing land use and climate change and as societal attitudes bring wildlife, livestock and people into closer contact. Animal and human health practitioners are encouraged to consider wildlife in their day to day activities and to learn more about Australia’s system and how they can become more involved by visiting www.wildlifeheathaustralia.com.au.

Pages

Subscribe to  Health Security Digest